Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial

scientific article

Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/QAI.0B013E31824F53A9
P932PMC publication ID3381429
P698PubMed publication ID22362152

P50authorThumbi Ndung'uQ1952473
Lise WernerQ70752228
Marcus AltfeldQ72531060
Sengeziwe SibekoQ72617850
Marianne W MureithiQ92059613
Quarraisha KarimQ17612495
Salim Abdool KarimQ18161438
Vivek NaranbhaiQ54258762
P2093author name stringNompumelelo P Mkhwanazi
Danielle Poole
CAPRISA004 Trial Group
Shabashini Reddy
P2860cites workImmune control of HIV-1 after early treatment of acute infectionQ56961920
Immunology and the elusive AIDS vaccineQ59098671
Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infectionQ62091094
An intrinsic way of multiclassification of endogenous psychoses. A follow-through investigation/Budapest 2000/based upon Leonhard's classificationQ95785042
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tractQ22242965
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in womenQ24629582
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.Q33649753
HIV preferentially infects HIV-specific CD4+ T cellsQ33958893
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsQ33981572
Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionalityQ34195857
Evidence of dysregulation of dendritic cells in primary HIV infectionQ34310896
AIDS vaccines and preexposure prophylaxis: is synergy possible?Q35003539
Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infantsQ36315692
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.Q36369035
Rapid loss of dendritic cell and monocyte responses to TLR ligands following venipunctureQ37036594
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cellsQ37256675
T cell immunity in acute HIV-1 infection.Q37789345
The immune response to AIDS virus infection: good, bad, or both?Q40643992
Evolution of innate and adaptive effector cell functions during acute HIV-1 infectionQ43425543
Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cellsQ43494949
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.Q44451245
Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infectionQ45654002
Loss of Viral Control in Early HIV‐1 Infection Is Temporally Associated with Sequential Escape from CD8+T Cell Responses and Decrease in HIV–1–Specific CD4+and CD8+T Cell FrequenciesQ56876055
P433issue2
P407language of work or nameEnglishQ1860
P921main subjecttenofovirQ155954
P304page(s)124-127
P577publication date2012-06-01
P1433published inJournal of Acquired Immune Deficiency SyndromesQ6294722
P1476titlePreservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial
P478volume60